Skip to main content
. 2020 Jul 7;11:1005. doi: 10.3389/fphar.2020.01005

Figure 5.

Figure 5

PF-6142 effects on ketamine-induced working memory deficits. (A) Pre-treatment with PF-6142 dose-dependently prevents ketamine-induced deficits in the rat radial arm maze assay. Data are presented as mean errors + SEM. Kruskal-Wallis test with Dunn’s multiple comparison post-test *p < 0.05, **p < 0.01 vs. vehicle + ketamine. N=10–21. (B) Treatment with PF-6142 prevents ketamine-induced deficits in the non-human primate spatial delayed response task. One-way ANOVA with Dunnett’s post-test adjusted *p < 0.05 vs. vehicle + Ketamine and N = 8 NHP.